Target intelligence / Profile preview

Human telomeric G-quadruplex DNA (hTel G4)

Target
hTel G4
Molecular classification
Nucleic acid, G-quadruplex, Non-canonical DNA structure
01

Overview

Human telomeric G-quadruplex DNA is a non-canonical secondary structure formed by the guanine-rich tandem repeats (TTAGGG) at the ends of human chromosomes [6, 7]. These structures are composed of stacked G-tetrads stabilized by Hoogsteen hydrogen bonds and monovalent cations, typically potassium or sodium [1, 6]. In most cancer cells, telomere length is maintained by the overexpressed enzyme telomerase, which prevents the natural senescence that occurs in somatic cells [3, 12]. Small molecule ligands designed to target and stabilize these G-quadruplexes can physically block telomerase access and displace protective shelterin proteins like POT1 [2, 13]. This uncapping of the telomere is recognized by the cell as a double-strand break, triggering a robust DNA damage response that leads to apoptosis or permanent growth arrest [2, 10]. As such, the human telomeric G-quadruplex represents a promising therapeutic target for broad-spectrum anticancer drug development [4, 8].

Other names
Telomeric G-quadruplexhTel G4Human telomeric G4Telomeric DNA G-quadruplexhTel-G4G4-DNA
02

Mechanism of action

Stabilization of the G-quadruplex structure at the 3' telomeric overhang, which inhibits telomerase-mediated telomere extension and displaces telomere-binding proteins such as POT1, leading to telomere uncapping, activation of the DNA damage response, and subsequent induction of apoptosis or senescence [2, 6, 10].

03

Biological functions

Telomere maintenanceTelomerase inhibitionChromosome end protectionDNA damage response inductionCellular senescence regulation
04

Disease associations

CancerAging
05

Safety considerations

Off-target effects on other genomic G-quadruplexesPotential for systemic toxicity in high-turnover healthy tissuesInduction of genomic instabilityChallenges in achieving high structural selectivity [4, 13]
06

Interacting drugs

BRACO-19

6 more in the full profile.

07

Biomarkers

Telomere lengthTelomerase activityhTERT expressionTelomere dysfunction-induced foci (TIFs)Gamma-H2AX

Beyond the preview

Go deeper on Human telomeric G-quadruplex DNA (hTel G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human telomeric G-quadruplex DNA (hTel G4).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call